Ronald Vogels

7.1k total citations · 1 hit paper
40 papers, 3.7k citations indexed

About

Ronald Vogels is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Ronald Vogels has authored 40 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 24 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Ronald Vogels's work include Virus-based gene therapy research (23 papers), CAR-T cell therapy research (14 papers) and Viral Infectious Diseases and Gene Expression in Insects (12 papers). Ronald Vogels is often cited by papers focused on Virus-based gene therapy research (23 papers), CAR-T cell therapy research (14 papers) and Viral Infectious Diseases and Gene Expression in Insects (12 papers). Ronald Vogels collaborates with scholars based in Netherlands, United States and France. Ronald Vogels's co-authors include Jaap Goudsmit, Menzo Havenga, Angelique A. C. Lemckert, Wouter Koudstaal, Dan H. Barouch, Lennart Holterman, Jacqueline Deschamps, Boerries Brandenburg, Robert H. Friesen and Ted Kwaks and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Ronald Vogels

39 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

2011 660 citations Robert H. Friesen, Ted Kwaks et al. Science profile →

Peers

Countries citing papers authored by Ronald Vogels

Since Specialization

Citations

This map shows the geographic impact of Ronald Vogels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Vogels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Vogels more than expected).

Fields of papers citing papers by Ronald Vogels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Vogels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Vogels. The network helps show where Ronald Vogels may publish in the future.

Co-authorship network of co-authors of Ronald Vogels

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Vogels. A scholar is included among the top collaborators of Ronald Vogels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Vogels. Ronald Vogels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VHH antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusion 2025 ·PubMed ·Rameshwar U. Kadam, Jarek Juraszek, Boerries Brandenburg, Divita Garg, Xueyong Zhu, Mandy Jongeneelen, Wim Schepens, Bart Stoops, (unknown), (unknown), Chan Tang, Sven Blokland, Ronald Vogels, Robert H. Friesen, Maria J. P. van Dongen, Ian A. Wilson	0
2	De novo design of D-peptide ligands: Application to influenza virus hemagglutinin 2025 ·Proceedings of the National Academy of Sciences ·Jarek Juraszek, Rameshwar U. Kadam, Davide Branduardi, Jeroen van Ameijde, Divita Garg, (unknown), Mandy Jongeneelen, (unknown), Just P. J. Brakenhoff, Boerries Brandenburg, Maria J. P. van Dongen, Ronald Vogels, Robert H. Friesen, Ian A. Wilson	1
3	Potent peptidic fusion inhibitors of influenza virus 2017 ·Science ·Rameshwar U. Kadam, Jarek Juraszek, Boerries Brandenburg, Christophe Buyck, Wim Schepens, Bart Kesteleyn, Bart Stoops, Rob J. Vreeken, (unknown), (unknown), Chan Tang, Ronald Vogels, Robert H. Friesen, Jaap Goudsmit, Maria J. P. van Dongen, Ian A. Wilson	120
4	HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids 2016 ·Frontiers in Immunology ·Freek Cox, Ted Kwaks, Boerries Brandenburg, Martin H. Koldijk, (unknown), (unknown), (unknown), Eric Geelen, Lisanne Tettero, David Zuijdgeest, Esther J. M. Stoop, Eiríkur Saeland, Ronald Vogels, Robert H. Friesen, Wouter Koudstaal, Jaap Goudsmit	48
5	Serum‐free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity 2007 ·Biotechnology and Bioengineering ·Menzo Havenga, Lennart Holterman, (unknown), (unknown), Jorn Kaspers, (unknown), Remko van der Vlugt, Martin H. Koldijk, G. J. Schouten, Guus Hateboer, (unknown), Ronald Vogels, Jaap Goudsmit	32
6	A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells 2006 ·Vaccine ·Giuseppe Marzio, (unknown), Johannes A. Bogaards, (unknown), Anke de Groot, (unknown), Gerrit Jan Weverling, Ronald Vogels, Menzo Havenga, Jerome Custers, Maria Grazia Pau, (unknown), John A. Lewis, Jaap Goudsmit	8
7	Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector 2004 ·AIDS ·Stefan Kostense, Wouter Koudstaal, Mieke Sprangers, Gerrit Jan Weverling, (unknown), (unknown), Ronald Vogels, Margreet Bakker, Ben Berkhout, Menzo Havenga, Jaap Goudsmit	131
8	The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells 2003 ·Journal of Molecular Medicine ·Alexandra M Pietersen, Saskia A. Rutjes, Joost van Tongeren, Ronald Vogels, John G. Wesseling, Mathieu H. M. Noteborn	9
9	Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU 2002 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Marion de Jong, Ronald Vogels, Menzo Havenga, (unknown), Willem H. Bakker, (unknown), C. J. J. Avezaat, (unknown), (unknown), (unknown), Edward E. Knaus, Leonard I. Wiebe, (unknown)	15
10	The Organotypic Multicellular Spheroid Is a Relevant Three-Dimensional Model to Study Adenovirus Replication and Penetration in Human Tumors in Vitro 2002 ·Molecular Therapy ·Jacques Grill, Martine L.M. Lamfers, Victor W. van Beusechem, Clemens M.F. Dirven, (unknown), (unknown), Paul van der Valk, Ronald Vogels, W. Peter Vandertop, Herbert M. Pinedo, David T. Curiel, Winald R. Gerritsen	53
11	The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissue 2001 ·Arthritis & Rheumatism ·Paulien H. Goossens, Ronald Vogels, Elsbet Pieterman, Menzo Havenga, A. Bout, Ferdinand C. Breedveld, Dinko Valerio, T. Huizinga	25
12	Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. 2001 ·PubMed ·(unknown), Ronald Vogels, Menzo Havenga, C. J. J. Avezaat, A. Bout, Peter Sillevis Smitt	86
13	Improved Adenovirus Vectors for Infection of Cardiovascular Tissues 2001 ·Journal of Virology ·Menzo Havenga, Angelique A. C. Lemckert, Jos Grimbergen, Ronald Vogels, L.G.M. Huisman, D. Valerio, A. Bout, Paul H.A. Quax	109
14	Prospects for chimeric adenoviruses. 2001 ·PubMed ·Menzo Havenga, Ronald Vogels, A. Bout	2
15	Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants 1999 ·Gene Therapy ·E Braakman, Ronald Vogels, Anton C. Martens, Jefrey Vermeulen, (unknown), Peter M. Hoogerbrugge, Daria G. Valerio, Anton Hagenbeek	4
16	Herpes Simplex Virus Thymidine Kinase Gene Therapy for Rat Malignant Brain Tumors 1996 ·Human Gene Therapy ·Audrey Vincent, Ronald Vogels, (unknown), (unknown), (unknown), C. J. J. Avezaat, (unknown), D. W. van Bekkum, D. Valerio, A. Bout, (unknown)	62
17	Regulation of the Hoxb-8 Gene: Synergism between Multimerized cis-Acting Elements Increases Responsiveness to Positional Information 1995 ·Developmental Biology ·Jeroen Charité, Wim de Graaff, Ronald Vogels, Frits Meijlink, Jacqueline Deschamps	43
18	Proximal cis-acting elements cooperate to set Hoxb-7 (Hox-2.3) expression boundaries in transgenic mice 1993 ·Development ·Ronald Vogels, Jeroen Charité, Wim de Graaff, Jacqueline Deschamps	47
19	The mouse homeobox gene, S8, is expressed during embryogenesis predominantly in mesenchyme 1991 ·Mechanisms of Development ·Dirk-Jan E. Opstelten, Ronald Vogels, Benoît Robert, Eric Kalkhoven, Fried Zwartkruis, (unknown), Olivier Destrée, Jacqueline Deschamps, Kirstie A. Lawson, Frits Meijlink	91
20	Carrot somatic embryogenesis depends on the phytohormone-controlled presence of correctly glycosylated extracellular proteins 1988 ·Genes & Development ·Sacco C. de Vries, H. Booij, Rodolphe Janssens, Ronald Vogels, (unknown), F Loschiavo, M. Terzi, A. van Kammen	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact